MARKETS
Technology

DataMeds AI's Pharmacy Unit Corexa Health Enters Agreement For Commercial Supply Of Six Peptides Recommended By The FDA Pharmacy Compounding Advisory Committee; Intends To Start Distributing Prescriptions In November 2026

Nov 2, 2026 · 06:06 AM ET· updated 2h ago

DataMEDS intends to leverage the Health Lives Here mobile application to help collect and report safety data, in accordance with U.S. Health and Human Services' (HHS) Enforcement Discretion Policy (EDP) published in

Share
Why It Matters

DataMeds got approval to sell six special medicines through pharmacies. This means the company is moving forward with a real business plan.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.